Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Treatment Of Systemic Sclerosis-Associated Interstitial Lung Disease (Ssc-ILD)

Publication Date: September 28, 2023

Last Updated: January 19, 2024

Treatment

The recommendation for the use of the following agent for the treatment of SSc-ILD is strong:

Mycophenolate

(Very low, Strong Recommendation)

3094444

Video

Overview

Title

Treatment Of Systemic Sclerosis-Associated Interstitial Lung Disease (Ssc-ILD)

Treatment Of Systemic Sclerosis-Associated Interstitial Lung Disease (Ssc-ILD)

Treatment

Video

Overview

Title

Authoring Organization